Luo Niancui, Li Zhenhao, Qian Dawei, Qian Yefei, Guo Jianming, Duan Jin-Ao, Zhu Min
Jiangsu Key Laboratory for High Technology Research of TCM Formulae, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, Jiangsu, PR China.
Jiangsu Key Laboratory for High Technology Research of TCM Formulae, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, Jiangsu, PR China.
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jul 15;963:29-39. doi: 10.1016/j.jchromb.2014.05.036. Epub 2014 May 27.
A highly sensitive and rapid ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) has been developed and validated for simultaneous quantification of seven components in rat plasma and five components in rat tissues after oral administration of the extracts of different combination Radix Angelicae Sinensis-Radix Paeoniae Alba herb couple and has been applied to compare the different pharmacokinetics and tissue distribution properties of these bioactive components. The extracts of Radix Angelicae Sinensis (RAS), Radix Paeoniae Alba (RPA) and Radix Angelicae Sinensis-Radix Paeoniae Alba herb couple (RRHC) were orally administrated to rats, respectively. The concentrations of ferulic acid, caffeic acid, vanillic acid, ligustilide, paeoniflorin, albiflorin and oxypaeoniflorin in rat plasma and the concentrations of ferulic acid, vanillic acid, paeoniflorin, albiflorin and oxypaeoniflorin in tissues were determined by UPLC-MS/MS. The plasma samples were pretreated by protein precipitation with methanol and the tissue samples were homogenated with water and pretreated by protein precipitation with methanol. Chromatographic separation was performed on a C18 column using 0.1% formic acid-acetonitrile as mobile phase for gradient elution. A triple quadrupole (TQ) tandem mass spectrometry equipped with an electrospray ionization source was used as detector operating both in positive and negative ionization mode and operated by multiple-reaction monitoring (MRM) scanning. Noncompartmental pharmacokinetic parameters were calculated by DAS 2.0 program. The differences between each group were compared by SPSS 16.0 with Independent-Samples T-test. The pharmacokinetic parameters (such as Cmax, Tmax, T1/2, AUC0-T, MRT0-T, Vz/F or CLz/F) of all the detected components between the single herb (RAS or RPA) and herb pair (RRHP) showed significant differences (P<0.05). It indicated that the compatibility of RAS and RPA could alter the pharmacokinetics features of each component. Tissue distribution results showed that ferulic acid, vanillic acid, paeoniflorin, albiflorin and oxypaeoniflorin mostly distributed in liver and kidney both in herb couple and single herb distributed most in liver and kidney. Compared with single herb, RRHC could increase or decrease the concentrations of five components at different time points compared with the sing herb. The results indicated the method was successfully applied to the comparative study on pharmacokinetics and tissue distribution of different combination of RRHC in rats. The compatibility of two Chinese herbs could alter the pharmacokinetics and tissue distribution properties of major bio-active components in the single herb. The results might be helpful for further investigation of compatibility mechanism of RRHC.
已开发并验证了一种高灵敏度快速超高效液相色谱 - 串联质谱法(UPLC-MS/MS),用于同时定量大鼠口服不同配伍的当归 - 白芍药对提取物后血浆中的七种成分和组织中的五种成分,并应用于比较这些生物活性成分的不同药代动力学和组织分布特性。分别给大鼠口服当归(RAS)、白芍(RPA)及当归 - 白芍药对(RRHC)的提取物。采用UPLC-MS/MS测定大鼠血浆中阿魏酸、咖啡酸、香草酸、藁本内酯、芍药苷、 albiflorin和氧化芍药苷的浓度以及组织中阿魏酸、香草酸、芍药苷、 albiflorin和氧化芍药苷的浓度。血浆样品用甲醇进行蛋白沉淀预处理,组织样品用水匀浆后用甲醇进行蛋白沉淀预处理。色谱分离在C18柱上进行,以0.1%甲酸 - 乙腈为流动相进行梯度洗脱。配备电喷雾电离源的三重四极杆(TQ)串联质谱用作检测器,在正离子和负离子电离模式下运行,并通过多反应监测(MRM)扫描进行操作。用DAS 2.0程序计算非房室药代动力学参数。用SPSS 16.0软件通过独立样本T检验比较各组之间的差异。单味药(RAS或RPA)与药对(RRHP)之间所有检测成分的药代动力学参数(如Cmax、Tmax、T1/2、AUC0-T、MRT0-T、Vz/F或CLz/F)均有显著差异(P<0.05)。这表明RAS与RPA的配伍可改变各成分的药代动力学特征。组织分布结果表明,阿魏酸、香草酸、芍药苷、 albiflorin和氧化芍药苷在药对及单味药中大多分布于肝脏和肾脏。与单味药相比,RRHC在不同时间点可使五种成分的浓度升高或降低。结果表明该方法成功应用于RRHC不同配伍在大鼠体内的药代动力学和组织分布的比较研究。两味中药的配伍可改变单味药中主要生物活性成分的药代动力学和组织分布特性。该结果可能有助于进一步研究RRHC的配伍机制。